West Pharmaceutical Services WST · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
413.09
+3.32%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About West Pharmaceutical Services
From its filings with the US Securities and Exchange Commission
West Pharmaceutical Services is based in Exton, Pennsylvania and is incorporated in Pennsylvania. Its shares trade on NYSE under the ticker WST. It is a member of the S&P 500. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $3.07bn and net income of $493.7m. At that date it held total assets of $4.27bn and shareholders' equity of $3.18bn. By business, Proprietary Products brought in 81.1% of revenue, followed by Contract-Manufactured Products at 18.9%. By region, United States accounted for 43.3%, followed by Other European countries at 14.7% and Germany at 12.4%.
We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently.
Our business operations are organized into two global business segments, Proprietary Products and Contract-Manufactured Products.
Our Proprietary Products reportable segment offers elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. Our packaging products include stoppers and seals for injectable packaging systems, which are designed to help ensure drug compatibility and stability with active drug products, while also supporting operational efficiency for customers.
Quoted from its 10-K, filed 17 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 27 Jul 1923
- Employees
- 10,800
- Website
- westpharma.com ↗
- Head office
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Incorporated in
- PA
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Eric GreenNon-Independent Chairman of the Board, President, Chief Executive Officer, since 2015$8.4m
- Mr. Robert McmahonChief Financial Officer, Senior Vice President
- Ms. Annette FavoriteChief Human Resources Officer, Senior Vice President$1.2m
- Mr. Shane CampbellSenior Vice President, Chief Proprietary Segment Officer
- Mr. Chad WintersChief Accounting Officer, Vice President - Finance
- Mr. Robert FrielLead Independent Director$342,653
- Mr. Mark ButhmanIndependent Director$376,944
- Dr. William FeeheryIndependent Director$358,660
- Ms. Janet HaugenIndependent Director$87,620
- Mr. Thomas HofmannIndependent Director$389,041
- Ms. Molly JosephIndependent Director$331,782
- Ms. Deborah Keller TannerIndependent Director$342,347
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 70
- Environment
- 40
- Social
- 77
- Governance
- 92
- Direct emissions (scope 1)
- 30,828 t
- Energy emissions (scope 2)
- 73,362 t
- Women in the workforce
- 36%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Established Market Presence: West Pharmaceutical Services Inc has a strong foothold in the global pharmaceutical packaging market, backed by its long history and reputation.
- Innovative Product Portfolio: The company offers a wide range of innovative packaging solutions and drug delivery systems that cater to the evolving needs of the pharmaceutical industry.
- Strong Customer Relationships: West Pharmaceutical Services Inc has built solid relationships with its global customer base, which includes leading pharmaceutical companies, allowing for long-term partnerships and repeat business.
Weaknesses
- Dependency on Pharmaceutical Industry: The company's business is heavily reliant on the demand and performance of the pharmaceutical industry, exposing it to potential economic downturns or regulatory changes.
- Limited Presence in Emerging Markets: West Pharmaceutical Services Inc has limited market penetration in emerging economies, which restricts its growth opportunities in regions with high pharmaceutical market potential.
- Vulnerability to Supply Chain Disruptions: Any disruptions in the supply chain, such as raw material shortages or logistics challenges, could negatively impact the company's production and delivery capabilities.
Opportunities
- Growing Pharmaceutical Market: The global pharmaceutical market is expanding, driven by increased healthcare spending and the demand for advanced drug delivery systems. West Pharmaceutical Services Inc can capitalize on this growth by continuously innovating and offering new solutions.
- Expansion into Emerging Markets: Developing a stronger presence in emerging economies, particularly in Asia and Latin America, could provide West Pharmaceutical Services Inc with access to new customers and untapped market potential.
- Mergers and Acquisitions: Strategic acquisitions or partnerships can enable the company to expand its product portfolio and enter new market segments, enhancing its competitive position.
Threats
- Intense Competition: West Pharmaceutical Services Inc faces fierce competition from other established pharmaceutical packaging companies, as well as emerging players, which could negatively impact its market share and profitability.
- Regulatory and Compliance Risks: The company operates in a highly regulated industry, and non-compliance with quality standards or changing regulations can result in legal issues or product recalls.
- Technological Advancements: Rapid technological advancements in the pharmaceutical packaging sector may require significant investments to stay ahead, posing challenges for West Pharmaceutical Services Inc to keep up with evolving customer demands.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.